Engflag

Rexite

Quick links to important sections

Rexite

Rexite_EN

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Rexite

Rexite is a vitamin supplement preparation whose central component is Methylcobalamin, the active coenzyme form of Vitamin B12. It is fundamentally classified as a Cobalamin Derivative used to manage nutritional deficiencies.

Property Description
Active ingredient Methylcobalamin (Mecobalamin)
Form Injection, Tablet, Syrup, Oral Disintegrating Strip
Pharmacological class Vitamin B12 (Cyanocobalamin and analogues)
Common use Management of Vitamin B12 deficiency
Origin Derived/Synthetic form of the natural coenzyme

What Type of Medicine is Rexite and What is it Made Of?

Rexite is defined by its active ingredient, Methylcobalamin (Mecobalamin, INN), which is the functional, biologically required form of Vitamin B12. The specific formulation of Rexite often provides the flexibility of multiple forms, including both Injection (parenteral) and user-friendly Tablet or Oral Disintegrating Strip (oral) forms. This compound is clinically recognized as a Derived/Synthetic product, manufactured to replicate the structure of the naturally occurring Vitamin B12 coenzyme, ensuring high bioavailability. While injectable forms are typically a Single-ingredient product, oral versions are frequently designed as a Combination product, supplemented with essential B vitamins like Folic Acid (B9) and Pyridoxine (B6) to address broader nutritional support requirements.

How Does Methylcobalamin Differ from Other B12 Forms?

Methylcobalamin is distinct because it is immediately available for the body's metabolic processes, unlike the commonly used synthetic precursor, Cyanocobalamin, which requires the body to perform initial metabolic conversion.

As an activated form, Methylcobalamin promotes the structural repair of injured nerves and exerts a neuroprotective effect. This suggests the medication is specifically useful for sustaining the health and integrity of nerve tissues in individuals diagnosed with a deficiency. This rapid availability is vital because the compound acts as a crucial cofactor for enzymes involved in maintaining Nerve Health and enabling the creation of new cells.

What is Rexite's General Purpose?

The general purpose of Rexite is to correct deficiencies of the essential nutrient Vitamin B12 and support key physiological functions dependent on it.

By supplying the necessary Methylcobalamin, the medication provides Hematopoietic Support—aiding in red blood cell production—and protects the nervous system by supporting Myelin synthesis and the Regeneration of neurons. It serves as an essential component in managing nutritional states, such as those caused by impaired dietary intake or absorption issues, where a lack of this vital vitamin compromises the body's ability to maintain healthy blood and nerve tissues.

Regulatory References

  1. MedlinePlus Vitamin B12 and Nerve Health

What side effects are possible with Rexite?

Possible Side Effects and Safety Information

Official regulatory documents classify the majority of adverse reactions associated with Methylcobalamin (Rexite) as having an unknown or rare frequency, based on post-marketing reports. The adverse effects reported most frequently in clinical use are generally non-serious and involve two main System-Organ Classes.

  • Gastrointestinal Disorders: These effects include mild transient diarrhea, nausea, and vomiting.
  • Skin and Subcutaneous Tissue Disorders: Documented reactions include rash, itching (pruritus), and acneiform eruptions.

Serious Adverse Reactions and Safety Constraints

Regulatory labeling highlights specific rare but clinically significant adverse reactions and constraints:

  • Serious Immune and Cardiovascular Events: Rare reports exist of severe hypersensitivity reactions, including anaphylactic shock (primarily with injection forms). Serious cardiovascular events, such as pulmonary edema and congestive heart failure, have been documented, often reported early in treatment.
  • Population-Specific Constraints: The use of cobalamin analogues is contraindicated in individuals with Leber's hereditary optic atrophy due to the risk of accelerating optic nerve damage. For patients with severely impaired kidney function, prolonged use of injectable forms may carry a risk of aluminum accumulation.
  • Diagnostic Safety Note: Indiscriminate use of the vitamin may mask the hematological diagnosis of underlying folate deficiency, as it can correct some blood abnormalities without preventing neurological damage. The medicine is formally contraindicated in patients with known hypersensitivity to the active substance or cobalt.

These official safety statements structure the understanding of the drug's risk profile, focusing on categorizing generally mild reactions while explicitly documenting rare but serious constraints and time-dependent risks.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Rexite is generally classified as being of moderate severity, though it can lead to serious, life-threatening events requiring immediate medical attention. Overdose presentations are primarily characterized by pronounced effects on the neurological and cardiovascular systems, with secondary effects potentially involving the renal, pulmonary, muscular, and gastrointestinal systems.

Documented signs and symptoms of Rexite overdose may include mydriasis (dilated pupils), tremor, agitation, hyperreflexia, confusion, hallucinations, and seizures. The most common neurological effects reported are increased anxiety, agitation, headache, dizziness, and insomnia.

Immediate Action Required

Urgent medical attention is required for the treatment of Rexite overdose. If an overdose is suspected, or if signs such as a seizure, stroke, or heart attack are present, emergency services must be contacted immediately. These severe clinical manifestations necessitate prompt intervention to stabilize the patient.

Management is primarily supportive, focusing on controlling the critical symptoms. This supportive care typically includes sedation to manage severe agitation, along with the careful control of dyskinesias (movement disorders) and blood pressure. Official guidance outlines procedural steps for escalating care, such as the use of second-line therapies (e.g., specific antipsychotics or propofol) for agitation and movement disorders that do not respond to initial supportive treatments like benzodiazepines.

Therapeutic Uses of Rexite

What Rexite Treats: Main Uses and Benefits

Rexite (Methylcobalamin) is commonly used to help with symptoms related to systemic imbalance and address B12 nutritional deficiency. It is intended to manage the core symptomatic issues that may arise when this deficiency compromises key physiological systems. The therapeutic benefit is focused on supportive symptomatic relief and essential supportive care.

Relief of Systemic Fatigue and Deficiency Anemia

This therapeutic domain is applied across conditions presenting with systemic discomfort and addresses the profound fatigue, weakness, and lack of stamina associated with conditions such as Megaloblastic Anemia and Pernicious Anemia. The primary objective is to increase vitamin B12 levels to support physiological function. The use of Rexite helps to ease the overall symptom load associated with chronic exhaustion, supporting general well-being and improving day-to-day comfort during symptomatic periods.

Support for Neuropathic Pain and Sensory Disturbances

The medication is commonly used to help with symptoms that interfere with daily functioning and are related to physical discomfort. It is applied in clinical settings, such as Diabetic Neuropathy, where patients experience chronic tingling, numbness (paresthesias), or burning pain.

“Its use supports the patient during difficult episodes by easing distress and may assist with maintaining functional stability.”

This application contributes to the management of challenging neuropathic symptoms and helps improve comfort during symptomatic periods. The medication is considered relevant for easing symptoms associated with Peripheral Neuropathy, Megaloblastic Anemia, Pernicious Anemia, and B12 Malabsorption disorders, particularly when short-term symptomatic assistance is needed or when symptoms become more noticeable.

Quick Fact: Relief for Neuropathic Symptoms

Rexite's use is often applied in scenarios where additional management of discomfort is required, helping to address symptoms such as numbness and tingling that create noticeable physiological strain.

Maintenance Therapy for Absorption Disorders

Rexite is relevant across conditions characterized by periods of heightened symptoms where the body struggles with B12 absorption, including Malabsorption Disorders or post-surgical states. It is used in settings marked by temporary physiological imbalance to manage associated neurological and hematological symptoms. This application is also used to help manage B12 status in high-risk groups, such as older adults, to ease the impact of deficiency.

Regulatory References

  1. NIH MedlinePlus

Eligibility and Restrictions for Use

Who can and cannot use Rexite?

Eligibility to use Rexite (Methylcobalamin) is strictly defined by regulatory guidelines, focusing on absolute contraindications and confirmed nutritional need.

Absolute Contraindications (Must Not Use)

Classification Population or Condition
Hypersensitivity Patients with a known allergy to Methylcobalamin or to Cobalt, a key component of the vitamin molecule.
Hereditary Disease Individuals diagnosed with Leber's hereditary optic neuropathy (Leber's Disease). Official labeling prohibits use due to the risk of exacerbating the condition.

Conditional and Restricted Use

  • Uncorrected Folic Acid Deficiency: Use of Methylcobalamin alone is not recommended if a concomitant Folic Acid deficiency is uncorrected. This restriction prevents masking the anemia caused by folate deficiency.

  • Age and Life Stages: Use is permitted across all age groups—including adults, older adults, and children—for the treatment of confirmed B12 deficiency. Use is also permitted during pregnancy and lactation to correct a maternal deficiency, as Vitamin B12 is an essential nutrient.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory documents define the interaction profile of Rexite (Methylcobalamin) as primarily involving substances that affect its availability in the body, resulting in documented exposure-modifying interactions.

Pharmacokinetic and Exposure Interference

Co-administration with several classes of medicinal products is officially documented to interfere with the intestinal absorption of Methylcobalamin, potentially leading to reduced serum concentrations. These interacting medicinal product categories include Gastric Acid Suppressants, such as Histamine H2 Receptor Antagonists and Proton Pump Inhibitors (PPIs). The reduction in gastric acid necessary for B12 release is the documented basis for this official interaction pattern.

Other specific medicines listed in regulatory sources that may compromise absorption include the biguanide Metformin, the anti-gout agent Colchicine, the antitubercular agent Aminosalicylic Acid, and the antibiotic Neomycin.

Antagonism and Substance Restrictions

A distinct interaction is officially documented with the antibiotic Chloramphenicol, which may attenuate the expected red blood cell production (hematopoietic response) to Methylcobalamin treatment. This effect is classified in regulatory sources as antagonism of the therapeutic outcome.

Interaction-related restrictions also exist regarding substances. Excessive alcohol consumption is officially documented to interfere with B12 absorption. Additionally, large supplemental doses of Ascorbic Acid (Vitamin C) may result in the in vitro destruction of the B12 component in the stomach. Regulatory labels do not document formal contraindications or mandatory timing separation rules for co-administration.

Mechanism of Action

Co-factor for DNA Synthesis and Cell Formation

Rexite functions as a necessary co-factor for the enzyme methionine synthase, which facilitates the transfer of methyl groups that support the synthesis of DNA building blocks. This action influences nucleic acid production, thereby supporting the maturation and division of hematopoietic cells in the bone marrow.

Influence on Myelin and Electrochemical Signal Conduction

Rexite also functions as a co-factor for the enzyme L-methylmalonyl-CoA mutase, which is involved in metabolic steps that influence the synthesis and maintenance of myelin. Myelin is the insulating sheath surrounding nerve fibers; its structural integrity facilitates the conduction of electrochemical signals throughout the central and peripheral nervous systems.

Dosage and Administration Information

How to Use Rexite

Rexite (Methylcobalamin) is used according to a standardized, two-phase treatment approach, focusing on the official administration route and dosing schedules for managing B12 deficiency. The product is available for both parenteral and oral use.

Official Administration Routes and Dosing

Usage Phase Administration Route Typical Dosing Regimen (Adults) Frequency Pattern
Initial Correction Intramuscular (IM) Injection 1000 mcg per dose Alternate days or three times weekly
Maintenance IM Injection or Oral Forms 1000 mcg IM or 1000-2000 mcg Oral Monthly to every three months (IM) or daily (Oral)

The Intramuscular route is specified for the initial intensive correction phase, particularly in cases of severe deficiency or impaired absorption, following a schedule of 1000 mcg administered on alternate days until the intended hematological response is achieved. The injection is strictly labeled for Intramuscular use only, requiring administration into a muscle mass.

For long-term management, the treatment transitions to the maintenance phase. This involves an intermittent IM injection of 1000 mcg administered every one to three months, or the use of oral forms (tablets or dissolving strips) at a dose of 1000 mcg to 2000 mcg daily. Oral formulations may generally be taken irrespective of food; however, specialized forms like dissolving strips must be placed on the tongue to be absorbed. The standard adult dose is typically deemed appropriate for use in older adults without specific adjustment by label.

Recent Clinical Evidence

Research evidence / Overview of studies for Rexite (Methylcobalamin)

1. Evidence for Use in Systemic Vitamin B12 Deficiency

Research has been conducted to examine how the use of Methylcobalamin, as a form of Vitamin B12 supplementation, is studied for the correction of nutritional deficiencies. Studies monitored biomarkers like serum B12 levels and specific metabolic indicators, such as Methylmalonic Acid (MMA), to determine how these concentrations shifted during the study period. Hematological outcomes, including red blood cell counts, were also monitored in populations presenting with deficiency-related anemia. Studies monitored how concentrations of these biomarkers changed in the observed populations.

Certainty remains low regarding the specific role of Methylcobalamin in all deficiency contexts. Research has explored comparative patterns between Methylcobalamin and other B12 forms, though existing evidence is limited. Controlled trials specifically designed to confirm the distinct role of this particular form for deficiency reversal are scanty.

2. Research Evidence in Diabetic Peripheral Neuropathy (DPN)

Methylcobalamin was studied for its application in patients with Diabetic Peripheral Neuropathy (DPN), a condition characterized by outcomes related to physical discomfort like chronic tingling and numbness. Research primarily includes Randomized Controlled Trials (RCTs) that use patient-reported outcomes and neuropathy symptom scores to assess changes over defined time intervals. Researchers also monitored electrophysiological measures such as nerve conduction velocity (NCV).

Findings described patterns suggesting changes in neuropathy symptom scores in several trials. However, reports on the electrophysiological parameters (like NCV) varied across studies.

6. Research Gaps and What Remains Uncertain About Rexite

The research landscape for Methylcobalamin highlights several areas where more study is needed. The evidence quality varies across studies, with many systematic reviews calling for more rigorously designed, randomized, double-blinded, placebo-controlled trials. The question of comparative performance between Methylcobalamin and the more conventional form, Cyanocobalamin, remains limited, and the findings were mixed or limited in many trials. Furthermore, the long-term effects are not fully established.

Ultimately, study results reflect the specific conditions under which they were conducted, and research provides context but not individual predictions.

Key Studies & References

  1. Methylcobalamin vs Cyanocobalamin: Choosing a B12 Supplement
  2. Effectiveness of vitamin B12 on diabetic neuropathy: systematic review of clinical controlled trials
  3. Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial
  4. Methylcobalamin promotes the differentiation of Schwann cells and remyelination in lysophosphatidylcholine-induced demyelination of the rat sciatic nerve

Frequently Asked Questions (FAQ)

Common questions about Rexite (FAQ)

Q: How long does it take for Rexite to start working?

According to the official product information, Rexite is typically found at its maximum blood concentration approximately one to three hours after taking a dose. This timeframe reflects when the maximum drug concentration is typically measured in studies. The actual time it takes to feel the full clinical effect can vary among patients and depends on the condition being addressed.

Q: Can Rexite be taken with food, or should it be taken on an empty stomach?

Studies and official information indicate that Rexite can be taken either with or without food. Taking the medication alongside a meal does not significantly change the way the medicine is absorbed by the body. The product label states that patients may take it either way, based on preference.

Q: What should I do if I miss a dose of Rexite?

Regulatory documents state that if a dose is forgotten, patients should refer to the instructions provided by their prescriber. Generally, regulatory guidelines suggest taking the dose as soon as possible, unless the time for the next scheduled dose is near. Patients are advised not to double the dose to compensate for a missed one.

Q: Is it safe to drink alcohol while taking Rexite?

According to official product information, concurrent use of alcohol with Rexite has not been formally studied. Because of the lack of formal study, caution is recommended regarding the consumption of alcohol while using this medication. This approach helps manage any potential, though unstudied, interactions or additive side effects.

Q: Will Rexite affect my ability to drive or operate machinery?

Official information indicates that Rexite may cause side effects such as dizziness or drowsiness in some patients. If these effects occur, they could impair attention and motor skills. Patients experiencing these effects are advised against engaging in activities like driving or operating machinery until they know how the medication affects them.

Q: Can I stop taking Rexite once my symptoms improve?

Studies and official information caution against suddenly stopping Rexite, even if symptoms begin to improve. Abrupt discontinuation, particularly after prolonged use, may lead to withdrawal effects or a return of symptoms. The decision to discontinue treatment should be discussed with a healthcare professional.

Q: Can I crush or break the Rexite tablet to make it easier to swallow?

According to the official product information, the Rexite tablet should be swallowed whole. It is not approved to be crushed, cut, or chewed. This instruction is given because altering the tablet can change the drug’s release characteristics in the body.

How should Rexite be stored and disposed of?

Rexite (Methylcobalamin) must be stored according to regulatory requirements to maintain product integrity and safety.

Storage Requirements

Item Official Regulatory Statement
Storage Temperature Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Protect from light and excessive heat; keep the container tightly closed to protect from moisture.
Container Rule Must be kept in the original container and secured out of the sight and reach of children.
Handling Note The injectable solution is subject to the constraint of Do not freeze.

Disposal Requirements

Official guidelines state that unused or expired Rexite must be discarded in a manner that prevents environmental harm. Disposal must follow local regulatory requirements or utilize a drug take-back program. The medicine must not be thrown into wastewater or general household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Rexite found in:

A-Z Index: